Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope and concerns about transparency and ethics.

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

The company brings together AI experts and experienced pharmaceutical scientists to build what Murdoch calls a “world-class drug design engine.” In 2024, Isomorphic signed major research deals ...

The foundational model could also assist Google and partner Samsung in an ongoing rivalry with Apple, currently the leader in ...

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...

Clinical trials remain the cornerstone of evidence-based medicine, yet they are frequently protracted and costly. More often ...